The left atrium in hypertension: Next to the chamber of power

Journal of Hypertension

Volumn 22, Issue 8, 2004, Pages 1473-1474

  Jennings, Garry L R ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPARATIVE STUDY; HEART ATRIUM FIBRILLATION; HEART HEMODYNAMICS; HEART LEFT ATRIUM; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MEDICAL LITERATURE; METHODOLOGY; NOTE; ORGAN SIZE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 3843061204     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000133713.55957.ec     Document Type: Note

References (11)

1. Krahn AD, Manfrede J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors and prognosis in the Manitoba Follow-Up Study. Am J Med 1995; 98:476-484.
2. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82:2N-9N.
3. Verdecchia P, Riboldi G, Gattaobigio R, Bentivoglio M, Borgioni C, Angeli F, et al. Atrial fibrillation in hypertension: predictors and outcome. Hypertension 2003; 41:218-223.
4. Cioffi G, Mureddu GF, Stefenelli C, de Simone G. The relationship between left ventricular geometry and left atrial size and function in patients with systemic hypertension. J Hypertens 2004; 22:1589-1596.
5. Mansoor GA, Suri R, White WB. Determinants of left atrial size in patients with newly diagnosed untreated hypertension. Blood Press Monit 2003; 8:3-7.
6. Cioffi G, Stefenelli C. Comparison of left ventricular geometry and left atrial size and function in patients with aortic stenosis versus those with pure aortic regurgitation. Am J Cardiol 2002; 90:601-606.
7. Gerdts E, Oikarinen L, Palmieri P, Otterstad JE, Wachtell K, Boman K, et al., for the Losartan intervention for endpoint reduction in hypertension (LIFE Study). Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan intervention for endpoint reduction in hypertension (LIFE Study). Hypertension 2002; 39:739-743.
8. Daniels SR, Witt SA, Glascock B, Choury PR, Kimball TR. LA size in children with hypertension; the influence of obesity, blood pressure and left ventricular mass. J Paediatr 2002; 141:159-161.
9. Laufer E, Jennings GL, Korner PI, Dewar E. Prevalence of cardiac structural and functional abnormalities in untreated primary hypertension. Hypertension 1989; 13:151-162.
10. Jennings G, Wong J. Reversibility of left ventricular hypertrophy and malfunction by antihypertensive treatment. In: Hansson L, Birkenhager W (editors): Handbook of hypertension, vol. 18: Assessment of hypertensive organ damage. Amsterdam: Elsevier Science BV; 1997, pp. 184-223.
11. Jennings G. Prospects for the non-pharmacological control of hypertension. In: McNeil JJ, King RWF, Jennings GL, Powles JW (editors): A textbook of preventative medicine. Melbourne: Edward Arnold Pty Ltd; 1990, pp. 133-145.